Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HRJ Biotech (HRJ-BIO) is a prominent Chinese medical technology company focused on the development and manufacturing of In Vitro Diagnostic (IVD) systems and reagents. The company operates a comprehensive business model encompassing R&D, production, and global sales, with its headquarters in Nanjing and specialized centers in Shenzhen and Changsha. Its product portfolio includes high-throughput hematology analyzers, biochemistry systems, chemiluminescence immunoassay platforms, and molecular diagnostic tools like portable PCR systems. With over 60 products certified by CE and NMPA, HRJ Biotech serves healthcare providers across more than 50 countries in regions such as South America, Southeast Asia, and Europe. The company is currently expanding its global footprint through the construction of a large-scale R&D and production center in the Nanjing Medical Device Industrial Park.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HRJ Biotech.